Bibliografía

2. Actuar es posible. El profesional de atención primaria de salud ante las drogodependencias. Junta de Andalucia. Consejeria de trabajo y Asuntos sociales.1994

3. Kleber HD. Our Current Approach to Drug Abuse-Progress, Problems, Proposals. New Engl J Medicine 1994; 330:361-365.

4. Escohotado A. Historia elemental de las drogas. Editorial Anagrama S.A.Barcelona 1996.

5. Li L, Smialek JE. Observations on Drug Abuse Deaths in the State of Maryland. J Forensic Sci 1996; 41:106-109.

6. Hoffman RS, Goldfrank LR. The Impact of Drug Abuse and Addition on Society. Emerg Med Clin North Am 1990: 8:407-480.

7. Males M. Discriminalisation of cannabis. Lancet 1995; 346:1708-9.

8. Hoover A, DeAngelis CD. Adolescent Medicine. JAMA 1994; 271:1651-53.

9. Ott J. Farmacotheon. Drogas enteógenas, sus fuentes vegetales y su historia. Los libros de la Liebre de Marzo, S.L.Barcelona 1996.

10. Barrio G, de la Fuente L, Camí J. El consumo de drogas en España y su posición en el contexto europeo. Med Clin 1993; 101:344-355.

11. Cabrera Bonet R, Cabrera Forneiro J. Las Drogas de Abuso: Un reto Sanitario. Universidad Pontificia de Comillas. Madrid 1994.

12. Plan nacional sobre Drogas. Memoria 1994. Ministerio de Justicia e Interior. Delegación del Gobierno para el Plan Nacional sobre Drogas. Madrid 1994.

13. Fiscal General del Estado. Memoria 1995.

14. Los Andaluces Ante Las Drogas IV. Junta de Andalucia. Consejeria de Trabajo y Asuntos Sociales. Comisionado para la droga. Sevilla 1995.

15. Angell M, Kassirer JP. Alcohol and others Drugs.Toward a more rational and consistent policy. N Engl J Med 1994; 331:537-539.

16. Billy I, Lejonc JL. Grandes complications somatiques de l'alcoolisation aiguë. Rev Prat 1993; 43:2047-51.

17. Levine B, Green D, Smialek JE. The role of ethanol in heroin deaths. J Forensic Sci 1995; 40:808-10.

18. Pontel G, Touze MD, Baron D. Intoxication éthilique aiguë. Rev Prat 1993; 43:2043-6.

19. Ritchie JM. Alcoholes Alifáticos. En: Gilman AG,Goodman LS,Rall TW,Murad F,eds.Goodman y Gilman.Las Bases Farmacológicas de la Terapéutica. Madrid:Editorial Medica Panamericana,1986: 364-377.

20. Paille F, Gillet C, Pirollet P. Phyysiopathologie de l´alcoolisation aiguë et du sevrage alcoolique. Rev Prt 1993; 43:2035-41.

21. Adès J, Lejoyeux M. Urgences psychiatriques dans l'alcooholisation aigüe. Rev Prat 1993; 43:2060-63.

22. Altura BM, Memon ZS, Altura BT, Cracco RQ. Alcohol-associated acute head trauma in human subjects is associated with early deficits in serum ionized Mg and Ca. Alcohol 1995; 12:433-7.

23. Levitt MA, Cook LA, Simon BC, Williams V. Biochemical markers of cerebral injury in patients with minor head trauma and ethanol intoxication. Acad Emerg Med 1995; 2:675-80.

24. Jurkovich GJ, Rivara FP, Gurney JG, Fligner C, Ries R, Mueller BA, Copass M. The effect of acute alcohol intoxication and chronic alcohol abuse on outcome from trauma. JAMA 1993; 270:51-6.

25. Bouget, J. Crises convulsives de l'alcolique en situation dúrgence. Rev Prat 1993; 43:2052-2055.

26. Laurent B, Garnier P. Urgences neurologiques dans l'alcoolisation aigüe. Rev Prat 1993; 43:2056-2059.

27. Aubin HJ, Barrucand D, Aupezy Ph. Syndrome de sevrage alcoohique et delirium tremens leur traitement. Rev Prat 1993; 43:2064-2070.

28. Hubbell KC. Opiates and Narcotics. En: Haddad LM, Winchester JF,eds. Clinical Management of Poisoning and drug overdose. Seocond edition. Philadelphia: WB Saunders, 1990; 706-717.

29. Diamant-Berger O, Gherardi R, Baud F, Alberti X, Galliot M, Blery O. Dissimulation intracorporelle de stupéfiants.Experérience des urgences médico-judiciaires de l'Hotel-Dieu de Paris:100 cas. Presse Med 1988; 17:107-110.

30. Roberts JR, Price D, Goldfrank L, Hartnett L. The bodystuffer syndrome: a clandestine form of drug overdose. Am J Emerg Med 1986; 4:24-7.

31. Collee GG, Hanson GC. The manegement of acute poisoning. Br J Anaesth 1993; 70:562-573.

32. Steentoft A, Teige B, Holmgren P, Vuori E, Kristinsson J, Kaa E, Wethe G, Ceder G, Pikkarainen J, Simonsen KW. Drug addict deaths in the Nordic countries: a study based on medicolegally examined cases in the five Nordic countries in 1991. Forensic Sci Int 1996; 77:109-18.

33. Chisholm CD, Furbee RB. Opioid Poisoning.En: Harwood-Nuss, Linden Luten, Shepherd and Wolfson,eds. The Clinical Practice of Emergency Medicine, second edition.Philadelphia:Lippicott-Raven Publishers, 1996; 1382-1386.

34. Blain PG, Lane RJ, Bateman DN, Rawlins MD. Opiate-induced rhabdomyolysis. Hum Toxicol 1985; 4:71-74.

35. Martin M, Hecker J, Clark R, Frye J, Jehle D, Lucid EJ, Harchelroad F. China White epidemic: an eastern United States emergency department experience. Ann Emerg Med 1991; 20:158-164.

36. Lheureux P, Debailleul G, De Witte O, Askenasi R. Zolpidem intoxication mimicking narcotic overdose: response to flumazenil. Hum Exp Toxicol 1990; 9:105-107.

37. Barturen F. Los psicoestimulantes como sustancia con potencial de abuso. En: Meana JJ y Barturen,eds. Psicoestimulantes: cocaína, anfetaminas y xantinas. Bilbao.Universidad de Deusto, 1993;15-29.

38. Sallés J, Dierssen M. Neurobilogia del abuso de anfetaminas y sustancias derivadas.En: Meana JJ y Barturen,eds. Psicoestimulantes: cocaína, anfetaminas y xantinas. Bilbao.Universidad de Deusto, 1993; 47-85.

39. Beebe DK, Walley E. Smokable methamphetamine ("ice"): an old drug in a different form. Am Fam Physician 1995; 51:449-53. 

40. Emerson TS, Cisek JE. Methcathinone: a Russian designer amphetamine infiltrates the rural midwest.Ann Emerg Med 1993; 2:1897-903.

41. Roberts L, Wright H. Survival following intentional massive overdose of 'Ecstasy'. J Accid Emerg Med 1994;11:53-54.

42. Le Gac JM, Picault L, Texier S, Berthouloux J, Pellerin R. Myocardial infarction during amphetamine poisoning. Presse Med 1996; 25:995.

43. Callaway CW, Clark RF. Hyperthermia in psychostimulant overdose. Ann Emerg Med 1994; 24:68-76.

44. Jones AL, Jarvie DR, McDermid G, Proudfoot AT. Hepatocellular damage following amphetamine intoxication. J Toxicol Clin Toxicol 1994; 32:435-444.

45. Jorens RG, Heytens L, Demey HE, Andries S. Acute poisoning with amphetamines (MDEA) and heroin: antagonistic effects between the two drugs. Intensive Care Med 1996; 22:456.

46. Derlet RW, Rice P, Horowitz BZ, Lord RV. Amphetamine toxicity: experience with 127 cases. J Emerg Med 1989; 7:157-161.

47. Logan B, Weiss EL, Harruff RC. Case report: Distribution of Methanphetamine in a Massive fatal Ingestion. J Forensic Sci 1996;41:322-323.

48. Davis GG, Swalwell CI. The Incidence of Acute Cocaine or Methanphetamine Intoxication in Deaths Due to Ruptured Cerebral (Berry) Aneurysms. J Forensic Sci 1996;41:626-628.

49. Renzi FP. Cocaine Poisoning.En: Harwood-Nuss, Linden, Luten, Sheperd y Woflson, eds. The Clinical Practice of Emergency Medicine, second edition. Philadelphia: Lippincott-Raven Publishers, 1996;1291-1294.

50. Hoffman RS, Henry GC, Howland MA, Weisman RS, Weil L, Goldfrank LR. Association between life-threatening cocaine toxicity and plasmacholinesterase activity. Ann Emerg Med 1992; 21:247-53.

51. Hoffman RS, Morasco R, Goldfrank LR. Administration of purified humanplasma cholinesterase protects against cocaine toxicity in mice. J Toxicol Clin Toxicol 1996; 34:259-66.

52. Marcovigi P, Leoni S, Calbi G, Valtancoli E, Granata A, Gudenzi P, Casadei C, Ravaglia G. Acute cocaine poisoning in a body packer. Minerva Anestesiol 1995; 61:109-12.

53. Aldrighetti L, Graci C, Paganelli M, Vercesi M, Catena M, Ferla G. Intestinal occlusion in cocaine-packet ingestion. Minerva Chir 1993; 48: 1233-1237.

54. Mueller PD, Benowitz NL, Olson KR. Cocaine. Emerg Med Clin North Am 1990; 8:481-493.

55. Katz AA, Hoffman RS, Silverman RA. Phenytoin toxicity from smoking crack cocaine adulterated with phenytoin. Ann Emerg Med 1993; 22:1485-1487.

56. Nogue S, Sanz P, Munne P, de la Torre R. Acute scopolamine poisoning after sniffing adulterated cocaine. Drug Alcohol Depend 1991; 27:115-116.

57. Insley BM, Grufferman S, Ayliffe HE. Thallium poisoning in cocaine abusers. Am J Emerg Med 1986; 4:545-548.

58. Stevens DC, Campbell JP, Carter JE, Watson WA. Acid-base abnormalities associated with cocaine toxicity in emergency department patients. J Toxicol Clin Toxicol 1994; 32:31-39.

59. Goldfrank LR, Hoffman RS. The cardiovascular effects of cocaine. Ann Emerg Med 1991; 20:165-175.

60. Merigian KS, Roberts JR. Cocaine intoxication: hyperpyrexia, rhabdomyolysis and acute renal failure. J Toxicol Clin Toxicol 1987; 25: 135-148.

61. Bernad M, Ibañez C, Medraño JC, Peña JM, Martinez MA, Juarez S. Rabdomiolisis en la intoxicación aguda por cocaína. An Med Interna 1990; 7: 631-634.

62. Towers CV, Pircon RA, Nageotte MP, Porto M, Garite TJ. Cocaine intoxication presenting as preeclampsia and eclampsia. Obstet Gynecol 1993: 81:545-547.

63. Riggs D, Weibley RE. Acute hemorrhagic diarrhea and cardiovascular collapse in a young child owing to environmentally acquired cocaine. Pediatr Emerg Care 1991; 7:154-155.

64. Ramoska E, Sacchetti AD. Propranolol-induced hypertension in treatment of cocaine intoxication. Ann Emerg Med 1985; 14:1112-1113.

65. Sheperd SM, Jagoda AS. Phencyclidine and the Hallucinogens. En: Haddad LM, Winchester JF,eds. Clinical Management of Poisoning and drug overdose.Second Edition. Philadelphia:WB.Saunders Company, 1990; 749-769.

66. Aaron CK, Ferm RP. Lysergic Acid Diethylamide and Others Psychedelics. En:Goldfrank's LR et al, eds.Toxicologic Emergencies. Fifth edition. Norwalk, Connecticut:Appleton and Lange, 1994;881-887.

67. Linden CH,Muse DA. Hallucinogen Poisoning. En: Harwood-Nuss, Linden, Luten, Shepherd, and Wollfson,eds. The Clinical Practice of Emergency Medicine. Second edition. Philadelphia:Lippincott-Raven Publishers, 1996;1335-1338.

68. Abraham HD, Aldridge AM. Adverse consequences of lysergic acid diethylamide. Addiction 1993; 88:1327-1334.

69. Kawasaki A, Purvin V. Persistent palinopsia Following Ingestion of Lysergic Acid Diethylamida (LSD). Arch Ophthalmol 1996; 114:47-49.

70. Kulig K. LSD.Emerg Med Clin North Am 1990; 8;551-558.

71. Spoerke DG, Hall AH. Plants and Mushrooms of Abuse. Emerg Med Clin North Am; 8:579-593.

72. Brust JC. Other agents. Phencyclidine, marijuana, hallucinogens, inhalants, and anticholinergics. Neurol Clin 1993; 11:555-561.

73. Baldrige E.B, Bessen H.A. Fhencyclidine. Emerg Med Clin North Am 1990; 8:541-550.

74. Renier S, Messi G, Orel P. Intossicazione acuta da Cannabis in una bambina. Minerv Pediat 1994; 46:335-338.

75. Macnab A, Anderson E, Susak L. Ingestion of cannabis: a cause of coma in children. Pediatr Emerg Care 1989; 5:238-239.

76. Medrano C, Manzano S, Sánchez A, Seriña C. Material radiopaco abdominal e intoxicación accidental por "Cannabis". Act Ped Esp 1996; 54: 367-368. 

77. Lacroix J, Gaudreault P, Gauthier M. Admision to a pediatric intensive care unit for poisoning:A review of 105 cases. Crit Care Med 1989; 17: 748-750.

78. Wylie AS, Scott RTA, Burnett SJ. Psychosis due to "skunk". BMJ 1995; 311:125.

79. Wierviorka S. Aspects médico-psychologiques de la consommation de cannabis. Rev Prat 1995; 45:1367-1370.

80. Selden BS, Clark RF, Curry SC. Marijuana. Emerg Med Clin North Am 1990; 8:527-539.

81. Szara S: Marijuana. En: Haddag LM, Winchester JF,eds. Clinical Management of Poisoning and drug overdose.Second edition. Philadelphia: WB Saunders Company, 1990; 737-748.

82. Debray H, Vidal F, Enjolras M. Intoxication au cannabis chez una enfat de 13 mois. La Presse Médicale 1987; 16:1807.

83. Hervás JA, Fiol M, Vidal C, Masip MC: Intoxicación por ingestión de hachis en niños. Med Clin 1987; 88:563.

84. Lan LSH, Bacciono E, Caubet A, Bressollette L, Verger C. Intoxication voluntaire aux produits atropiniques. Dix-sept observationts. La Prese Medicale 1990; 19:84.

85. Balsega JM, Martínez-Vázquez JM. Datura stramonium:¿un antiguo alucinógeno en auge?. Med Clin 1985; 84:715.

86. Linden CH. Volatile Substances of Abuse. Emerg Med Clin North Am 1990; 8:559-578.

87. Colado MI, Lorenzo P. MDMA (Extasis):Farmacologia y toxicologia. En: J Bobes,eds. Extasis.Aspectos farmacológicos, psiquiatricos y médico-legales. Barcelona: Ediciones en Neurociencias, 1995;1-46.

88. Bobes J. Extasis. Aspectos farmacológicos, psiquiátricos y médico-legales. Barcelona.Ediciones en Neurociencias, 1995.

89. de la Fuente de Hoz L, Rodriguez Arenas MA, Vicente Orta J, Sánchez Payá J, Barrio Anta G. Epidemiología del consumo de drogas de diseño en españa. Med Clin 1997; 108:54-61.

90. Barish P, Tintinali J. Designer Drugs and Amphetamines. En: Haddad LM, Winchester JF,eds. Clinical Management of Poisoning and drug overdose. Second edition. Philadelphia: WB Saunders, 1990;
770-779.

91. Fahal IH, Salloni DF, Bell GR. Acute renal faillure after ectasy. Br Med J 1992; 305:29.

92. Poklis A, Mackell MA, Drake WK. Fatal intoxication from 3,4-methylenedioxyamphetamine. J Forensic Sci 1979; 24:70-75.

93. Dowling GP, McDonough ET, Bost RO. "Eve" and "Ectasy":A report of five deaths associated with the use of MDEA and MDMA. J Am Med Asso 1987; 257:1615-1617.

94. Henry JA, Jeffreys KJ, Dawling S. Toxicity and death from
3,4-methylenedioxymethamphetamine("ectasy"). Lancet 1992; 340:384-387.

95. Matthai SM, Davidson DC, Sills JA, Alexandrou D. Cerebral oedema after ingestión of MDMA("ecstasy") and unrestricted intake of water. BMJ 1996; 313:1359.

96. Green R, Goodwing GR. Ectasy and neurodegeneration. BMJ 1996; 312:1493-1494.

97. Ford M, Hoffman RS, Goldfank LR. Opioids and Designer Drugs. Emerg Med Clin North Am 1990; 8:495-511.

98. Evanko D."Designer drugs". Treating the damage caused by basement chemists. Postgrad Med 1991; 89:67-71.

99. Beebe DK, Walley E. Substance abuse:the designer Drugs. Am Fam Physician 1991; 43:1689-1698.

100. Forrest ARW, Galloway JH, Marsh ID, Strachan GA, Clark JC. A fatal overdose with 3,4-methylenedioxyamphetamine derivatives. Forens Sci Intern 1994; 64:57-59.